Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020

SELL
$55.65 - $79.83 $7.95 Million - $11.4 Million
-142,943 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$56.98 - $72.41 $1,994 - $2,534
-35 Reduced 0.02%
142,943 $8.32 Million
Q4 2017

Feb 14, 2018

SELL
$53.3 - $74.56 $1,332 - $1,864
-25 Reduced 0.02%
142,978 $9.22 Million
Q3 2017

Nov 14, 2017

BUY
$43.46 - $52.49 $6.21 Million - $7.51 Million
143,003
143,003 $7.51 Million

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $945M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Consonance Capital Management LP Portfolio

Follow Consonance Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Consonance Capital Management LP with notifications on news.